Skip to content
by Legal Desire
6 December 2023

Latham & Watkins Advises Laminar, Inc. in US$400 Million Acquisition by Johnson & Johnson Medtech

Advising firms

Deal team

23 lawyers named
LawyerFirmSeniorityPracticeOffice
Hans Brigham Lead Latham & Watkins LLP Partner corporate Boston
Evan Smith Lead Latham & Watkins LLP Partner corporate Boston
Stefanie Vincent Latham & Watkins LLP Counsel corporate Not stated
Michael Casagrande Latham & Watkins LLP Associate corporate Not stated
Jake Hummer Latham & Watkins LLP Associate corporate Not stated
Galina Vujovic Latham & Watkins LLP Associate corporate Not stated
Sarah Gagan Latham & Watkins LLP Partner IP Boston
Arun Mohan Latham & Watkins LLP Associate IP Not stated
Heather Deixler Latham & Watkins LLP Partner data privacy Bay Area
Mitch Bennett Latham & Watkins LLP Associate data privacy Not stated
Grace Lee Latham & Watkins LLP Partner tax Bay Area
Derek Gumm Latham & Watkins LLP Associate tax Not stated
Josh Friedman Latham & Watkins LLP Partner benefits Boston
Alisa Hand Latham & Watkins LLP Associate benefits Not stated
Laura Waller Latham & Watkins LLP Associate employment Chicago
Betty Pang Latham & Watkins LLP Partner healthcare regulatory Bay Area
John Manthei Latham & Watkins LLP Partner FDA regulatory Washington, D.C.
Chad Jennings Latham & Watkins LLP Counsel FDA regulatory Not stated
Seth Olson Latham & Watkins LLP Associate FDA regulatory Not stated
Mandy Reeves Latham & Watkins LLP Partner antitrust Washington, D.C.
Josh Holian Latham & Watkins LLP Partner antitrust Bay Area
Héctor Armengod Latham & Watkins LLP Partner antitrust Brussels
Patrick English Latham & Watkins LLP Counsel antitrust Washington, D.C.

20 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.

REGISTER FREE SIGN IN

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value
USD 400m (US$400 million)
What the figure measures
Total transaction value
Client
Laminar, Inc.Sell-side
Counterparties
Johnson & Johnson Medtech (Buy-side)